Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 4
2008 2
2010 9
2011 18
2012 31
2013 23
2014 19
2015 20
2016 23
2017 14
2018 10
2019 13
2020 16
2021 31
2022 23
2023 21
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.
Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A. Yulug B, et al. Among authors: turkez h. Transl Neurodegener. 2023 Jan 26;12(1):4. doi: 10.1186/s40035-023-00336-2. Transl Neurodegener. 2023. PMID: 36703196 Free PMC article. Clinical Trial.
A systems biology approach for studying neurodegenerative diseases.
Lam S, Bayraktar A, Zhang C, Turkez H, Nielsen J, Boren J, Shoaie S, Uhlen M, Mardinoglu A. Lam S, et al. Among authors: turkez h. Drug Discov Today. 2020 Jul;25(7):1146-1159. doi: 10.1016/j.drudis.2020.05.010. Epub 2020 May 19. Drug Discov Today. 2020. PMID: 32442631 Review.
Therapeutic Potential of Ferulic Acid in Alzheimer's Disease.
Turkez H, Arslan ME, Barboza JN, Kahraman CY, de Sousa DP, Mardinoğlu A. Turkez H, et al. Curr Drug Deliv. 2022;19(8):860-873. doi: 10.2174/1567201819666211228153801. Curr Drug Deliv. 2022. PMID: 34963433 Review.
Addressing the heterogeneity in liver diseases using biological networks.
Lam S, Doran S, Yuksel HH, Altay O, Turkez H, Nielsen J, Boren J, Uhlen M, Mardinoglu A. Lam S, et al. Among authors: turkez h. Brief Bioinform. 2021 Mar 22;22(2):1751-1766. doi: 10.1093/bib/bbaa002. Brief Bioinform. 2021. PMID: 32201876 Free PMC article. Review.
Systems biology based drug repositioning for development of cancer therapy.
Turanli B, Altay O, Borén J, Turkez H, Nielsen J, Uhlen M, Arga KY, Mardinoglu A. Turanli B, et al. Among authors: turkez h. Semin Cancer Biol. 2021 Jan;68:47-58. doi: 10.1016/j.semcancer.2019.09.020. Epub 2019 Sep 27. Semin Cancer Biol. 2021. PMID: 31568815 Review.
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases.
Turkez H, Altay O, Yildirim S, Li X, Yang H, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Arif M, Yulug B, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Hacimuftuoglu A, Shoaie S, Zhang C, Nielsen J, Borén J, Uhlén M, Mardinoglu A. Turkez H, et al. Life Sci. 2023 Feb 1;314:121325. doi: 10.1016/j.lfs.2022.121325. Epub 2022 Dec 26. Life Sci. 2023. Retraction in: Life Sci. 2024 Jul 15;349:122712. doi: 10.1016/j.lfs.2024.122712. PMID: 36581096 Free article. Retracted.
216 results